NEW YORK CITY, NY / ACCESS Newswire / February 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...
Foster City, California Tuesday, February 25, 2025, 16:00 Hrs [IST] ...
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
Hosted on MSN1mon
EU medicines agency quits X, moves to BlueskyA MSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media ...
Patients should have faster access to newly developed drugs and medicines and the Government is prepared to adopt new ...
One of the main challenges identified by the research was that, although the European Medicines Agency (EMA) approves new ...
Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...
Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today ...
Belgian MEP Liesbet Sommen spoke with Euractiv about critical medicines shortages, EU Pharma Package progress, and SANT's evolving role.
C3i became the first contract development and manufacturing organization (CDMO) for cell and gene therapies in Canada to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results